<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01860547</url>
  </required_header>
  <id_info>
    <org_study_id>TYBID1</org_study_id>
    <nct_id>NCT01860547</nct_id>
  </id_info>
  <brief_title>Effects of Berries and Berry Fractions on Metabolic Diseases</brief_title>
  <official_title>The Effect of the Bioactives of Sea Buckthorn and Bilberry on the Risk of Metabolic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pakkasmarja Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saarioinen Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kiantama Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aromtech Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fazer Bakeries Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Satakunta Sea Buckthorn Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Finnish Berry Powders Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that the bioactive compounds of sea buckthorn berries (Hippophaë
      rhamnoides), their fractions, and bilberries (Vaccinium myrtillus). have positive effects on
      lipid and carbohydrate metabolism and will thus reduce the risk of developing metabolic
      diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the project was to investigate whether it is possible to reduce the risk of
      metabolic diseases with supplementing the diet with sea buckthorn berries (Hippophaë
      rhamnoides), their bioactive fractions, and bilberries (Vaccinium myrtillus). The study
      design was a randomized cross-over clinical trial. The participants were slightly and
      moderately overweight female subjects. In total, 110 female volunteers were recruited, and
      they followed four different berry diets (bilberry, sea buckthorn, sea buckthorn phenolic
      extract and sea buckthorn oil) in a randomized order for 33-35 days. Each intervention was
      followed by a wash-out period of 30-39 days. Blood samples were drawn and physical
      measurements were performed after each period. Eighty volunteers completed the study.
      Different markers of lipid and carbohydrate metabolism and inflammation were measured form
      the blood samples.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Alanine aminotransferase (ALAT)</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triacylglycerols</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum gamma-glutamyl transpeptidase</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum high-sensitivity C-reactive protein</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum soluble intercellular adhesion molecule</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum tumor necrosis factor -alpha</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum soluble vascular cell adhesion molecule</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum adiponectin</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum interleukine-6</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Subclasses of serum lipoproteins, serum fatty acids and lipid classes of serum</measure>
    <time_frame>Change from beginning to end of each berry treatment (duration of treatments average 33-35 days)</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>bilberry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sea buckthorn berry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sea buckthorn phenolic extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sea buckthorn oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bilberries</intervention_name>
    <description>Frozen bilberries, 100 g/d</description>
    <arm_group_label>bilberry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sea buckthorn berry</intervention_name>
    <description>Dried sea buckthorn berries, 20 g/d</description>
    <arm_group_label>sea buckthorn berry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sea buckthorn phenolic extract</intervention_name>
    <description>Ethanol-water extract from sea buckthorn berries, combined with maltodextrin, 14.6 g/d (7.3 g sea buckthorn extract + 7.3 g maltodextrin)</description>
    <arm_group_label>sea buckthorn phenolic extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sea buckthorn oil</intervention_name>
    <description>Sea buckthorn oil, 4 g (8 capsules)/d</description>
    <arm_group_label>sea buckthorn oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 26-34

          -  total cholesterol 4.5-8 mmol/l

          -  LDL chol &gt;2.5 mmol/l

          -  triglycerides &lt;4 mmol/l

          -  glucose &lt;6 mmol/l

          -  insulin &lt;25 mU/l

          -  blood pressure &lt;160/99 mm Hg

          -  hemoglobin &gt;120 g/l

          -  thyroid-stimulating hormone 0.3-4.2 mU/l

          -  ALAT &lt;60 U/l

          -  creatinine &lt;115 umol/l

        Exclusion Criteria:

          -  pregnancy

          -  menopause,

          -  regular smoking

          -  previously diagnosed diabetes (other than gestational)

          -  thyroid, renal, hematological, or hepatic dysfunction

          -  previous myocardial infarction

          -  cardiovascular medication

          -  treatment with regular medication other than allergy medication or joint lubricates

          -  on-going inflammatory disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jukka-Pekka Suomela, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Turku</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heikki Kallio, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University of Turku</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Turku, Dept of Biochemistry and Food Chemistry</name>
      <address>
        <city>Turku</city>
        <zip>FI-20014</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <results_reference>
    <citation>Lehtonen HM, Suomela JP, Tahvonen R, Yang B, Venojärvi M, Viikari J, Kallio H. Different berries and berry fractions have various but slightly positive effects on the associated variables of metabolic diseases on overweight and obese women. Eur J Clin Nutr. 2011 Mar;65(3):394-401. doi: 10.1038/ejcn.2010.268. Epub 2011 Jan 12.</citation>
    <PMID>21224867</PMID>
  </results_reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2013</study_first_submitted>
  <study_first_submitted_qc>May 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2013</study_first_posted>
  <last_update_submitted>May 20, 2013</last_update_submitted>
  <last_update_submitted_qc>May 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turku</investigator_affiliation>
    <investigator_full_name>Jukka-Pekka Suomela</investigator_full_name>
    <investigator_title>University Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

